{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230629",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "74667",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208969Orig1s001ltr.pdf",
              "date": "20230630",
              "type": "Letter"
            },
            {
              "id": "74681",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208969s001lbl.pdf",
              "date": "20230703",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20260616",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "86243",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208969s002lbl.pdf",
              "date": "20260616",
              "type": "Label"
            },
            {
              "id": "86244",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/208969s002ltr.pdf",
              "date": "20260616",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230307",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "73708",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208969s000lbl.pdf",
              "date": "20230308",
              "type": "Label"
            },
            {
              "id": "73709",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/208969Orig1s000ltr.pdf",
              "date": "20230308",
              "type": "Letter"
            },
            {
              "id": "74007",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/208969Orig1s000TOC.html",
              "date": "20230417",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA208969",
      "sponsor_name": "AMPHASTAR PHARMS INC",
      "openfda": {
        "application_number": [
          "NDA208969"
        ],
        "brand_name": [
          "REXTOVY"
        ],
        "generic_name": [
          "NALOXONE HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "International Medication Systems, Ltd."
        ],
        "product_ndc": [
          "76329-3669"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "NASAL"
        ],
        "substance_name": [
          "NALOXONE HYDROCHLORIDE"
        ],
        "rxcui": [
          "2637879",
          "2680741"
        ],
        "spl_id": [
          "25c8bc5f-61d9-4f9e-9ce5-99c9083e2caa"
        ],
        "spl_set_id": [
          "fe9735db-c57e-44a8-bffb-b87a84c2a6f3"
        ],
        "package_ndc": [
          "76329-3669-2"
        ],
        "unii": [
          "F850569PQR"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "REXTOVY",
          "active_ingredients": [
            {
              "name": "NALOXONE HYDROCHLORIDE",
              "strength": "4MG/SPRAY"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SPRAY, METERED",
          "route": "NASAL",
          "marketing_status": "Over-the-counter"
        }
      ]
    }
  ]
}